|
Popular Press
CXL Explained
|
PACK-Crosslinking for infectious keratitis
Emagine
New article giving an overview about the current state of this exciting new field of corneal cross-linking.
A therapy to treat a global problem
Emagine
Cataract & Refractive Surgery Europe Today. Infectious keratitis…
Award for Spin-off company
Emagine
EMAGine SA, a spin-off company from the University of Geneva and co-founded by Nikki and Farhad Hafezi, is elected amongst the best start-ups in Switzerland in 2014.
New CXL protocol for corneal infections
Emagine
Ocular Surgery News An optimized treatment protocol, a…